119 related articles for article (PubMed ID: 2008785)
1. Granulocyte-macrophage colony-stimulating factor in neutropenia.
Hogan KR; Peters MD
DICP; 1991 Jan; 25(1):32-5. PubMed ID: 2008785
[No Abstract] [Full Text] [Related]
2. Towards improved cancer therapy using subcutaneously administered hemopoietic colony stimulating factors.
Morstyn G; Sheridan W; Lieschke G; Cebon J; Layton J; Fox R
Prog Clin Biol Res; 1990; 354B():29-36. PubMed ID: 1700441
[No Abstract] [Full Text] [Related]
3. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
Wong SF; Chan HO
Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
[TBL] [Abstract][Full Text] [Related]
4. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
Garavelli PL; Berti P
Recenti Prog Med; 1993; 84(7-8):526-30. PubMed ID: 8356307
[TBL] [Abstract][Full Text] [Related]
5. Growth factor frenzy.
Quesenberry PJ
Exp Hematol; 1993 Jul; 21(7):835-6. PubMed ID: 7686499
[No Abstract] [Full Text] [Related]
6. [Treatment of neutropenia in HIV infection with hematopoietic growth factors].
Moreno García M; Fernández González F
Rev Clin Esp; 1996 Apr; 196(4):248-54. PubMed ID: 8701065
[No Abstract] [Full Text] [Related]
7. [Place of CSF in pediatric oncology].
Hartmann O; Valteau-Couanet D
Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
[No Abstract] [Full Text] [Related]
8. Use of granulocyte-macrophage colony-stimulating factor for reversal of neutropenia following combined kidney-pancreas transplantation.
Squiers EC; Elkhammas EA; Henry ML
Transplant Proc; 1995 Dec; 27(6):3092-3. PubMed ID: 8539860
[No Abstract] [Full Text] [Related]
9. [First experience with the use of granulocyte-macrophage colony stimulating factor in pediatric oncology].
Ferencz T; Csáki C; Koós R; Schuler D; Borsi J
Orv Hetil; 1993 Jul; 134(27):1469-73. PubMed ID: 8351131
[TBL] [Abstract][Full Text] [Related]
10. Use of granulocyte-macrophage colony-stimulating factor in leukopenic renal transplant recipients.
Page B; Morin MP; Mamzer MF; Thervet E; Legendre C
Transplant Proc; 1994 Feb; 26(1):283. PubMed ID: 8108982
[No Abstract] [Full Text] [Related]
11. [Hematopoietic growth factors in treatment of infections in children with cancer].
Riikonen P
Duodecim; 1995; 111(20):1931-5. PubMed ID: 9841143
[No Abstract] [Full Text] [Related]
12. A tale of two growth factors.
Fruehauf JP; Kong KM; Wong SF; Chan HO
Pharmacotherapy; 2006 Mar; 26(3):443-4; discussion 444. PubMed ID: 16503728
[No Abstract] [Full Text] [Related]
13. Granulocyte-macrophage-colony-stimulating factor in established febrile neutropenia.
Mitchell PL; Pinkerton CR
J Clin Oncol; 1999 Sep; 17(9):3002. PubMed ID: 10561379
[No Abstract] [Full Text] [Related]
14. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
Rossi JF
Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
[No Abstract] [Full Text] [Related]
15. [Appropriate use of granulocyte-colony stimulating factor].
Ohashi K; Kiura K
Nihon Rinsho; 2015 Feb; 73 Suppl 2():336-40. PubMed ID: 25831778
[No Abstract] [Full Text] [Related]
16. [Growth factors in oncology: effectiveness and prospects].
Ottmann OG; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF in chemotherapy-induced febrile neutropenia--a double-blind randomized study.
Arnberg H; Letocha H; Nõu F; Westlin JF; Nilsson S
Anticancer Res; 1998; 18(2B):1255-60. PubMed ID: 9615797
[TBL] [Abstract][Full Text] [Related]
18. Granulocyte-macrophage colony stimulating factor (GM-CSF) in malignancy.
Ozsoylu S
Pediatr Hematol Oncol; 1998; 15(5):471, 473. PubMed ID: 9783319
[No Abstract] [Full Text] [Related]
19. [Rational therapy with hematopoetic growth factors (G-CSF, GM-CSF) for patients in neutropenia].
Kahl C; Leithäuser M; Freund M
Dtsch Med Wochenschr; 2002 Jul; 127(27):1473-8. PubMed ID: 12098099
[No Abstract] [Full Text] [Related]
20. Interactive discussion on chemotherapy-related adverse events.
Adams VR; Lyman GH
Pharmacotherapy; 2000 Jul; 20(7 Pt 2):121S-125S. PubMed ID: 10905688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
